JeffreyMVenstromMD
Oncology • San Francisco, CAAssistant Professor, Medicine, University of California, San Francisco, School of Medicine
Are you Dr. Venstrom?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Aveneu Ste A502
Box 0324
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2545- Is this information wrong?
Summary
- Dr. Jeffrey Venstrom, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California and New York. He is an Assistant Professor at University of California.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2010
Johns Hopkins UniversityResidency, Internal Medicine, 2004 - 2006
Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2010 - 2016
NY State Medical License 2006 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 Start of enrollment: 2010 Feb 01
- Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 1 citationsThe Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer.Will H Jin, Liangliang Zhang, Ryon Graf, Kira Raskina, Hanna Tukachinsky, Richard S P Huang, Kimberly McGregor, Mohamed Alshalalfa, Helen Y Hougen, Anwar Khan, Sanoj P...> ;Clinical Genitourinary Cancer. 2024 Feb 1
- 4 citationsComprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis.Smruthy Sivakumar, Jessica K Lee, Jay A Moore, Julia Hopkins, Justin Y Newberg, Russell Madison, Ryon Graf, Alexa B Schrock, Erin Kobetz, Randy Vince, Idalid Franco, C...> ;The Lancet. Digital Health. 2023 Jun 1
- Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-m...Camille Laurent, Maria Flores, Loïc Chartier, Sarah Huet, Christopher R Bolen, Jeffrey M Venstrom, Catherine Chassagne-Clément, Peggy Dartigues-Cuilléres, Fréderic Cha...> ;British Journal of Haematology. 2023 Aug 1
- Join now to see all
Press Mentions
Providence and GRAIL Expand Partnership to Increase Access to Galleri® Multi-Cancer Early Detection ScreeningApril 4th, 2023- Detecting Cancers Through Blood Tests Holds Promise, but Major Hurdles RemainSeptember 25th, 2022
- Study: Blood Test Can ID Cancers Without Clear SymptomsSeptember 13th, 2022
- Join now to see all
